MEFV and myeloid sarcoma: Similar findings have been reported in Israeli and northern European Caucasian MS populations, where the presence of MEFV variants, particularly M694V and E148Q, suggests that these mutations may act as potential modifier genes or risk factors for MS (95, 96).